The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Medical patients are also responsible for 100% of the cost of medication, making it cost-prohibitive to many. Medical cannabis has been legal in Poland since 2017. Is CBD legal in Poland?

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. In countries, such as Canada and the U.S.,

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In It has 15 wholly owned subsidiary companies.

History 56

History Legalization Chronic Pain Pharmaceutical 56

The Cannigma

MAY 7, 2021

There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know? While these high standards are certainly good practice, it doesn’t adequately consider that cannabis is a plant, which means it does not have the same stability as chemical compounds.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40